OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
James A. McCubrey, Li V. Yang, Stephen L. Abrams, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2155-2155
Open Access | Times Cited: 30
James A. McCubrey, Li V. Yang, Stephen L. Abrams, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2155-2155
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
Dimitrios Stefanoudakis, Maximos Frountzas, Dimitriοs Schizas, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 2827-2844
Open Access | Times Cited: 22
Dimitrios Stefanoudakis, Maximos Frountzas, Dimitriοs Schizas, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 2827-2844
Open Access | Times Cited: 22
TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications
Chuqi Wang, Jordan Yong Ming Tan, N. L. Chitkara, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3069-3069
Open Access | Times Cited: 13
Chuqi Wang, Jordan Yong Ming Tan, N. L. Chitkara, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3069-3069
Open Access | Times Cited: 13
TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress
Kaili Zhu, Fei Su, Jingru Yang, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 9
Kaili Zhu, Fei Su, Jingru Yang, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 9
Genetic Mutation and Regulation in Pancreatic Ductal Adenocarcinoma Cancer: Developing Relevant Molecular Biomarkers
Xin Ai
Theoretical and Natural Science (2025) Vol. 90, Iss. 1, pp. 54-60
Closed Access
Xin Ai
Theoretical and Natural Science (2025) Vol. 90, Iss. 1, pp. 54-60
Closed Access
Pathway-specific genomic alterations in pancreatic cancer across diverse cohorts
Cecilia Monge, Brigette Waldrup, Francisco J. Carranza-Chávez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Cecilia Monge, Brigette Waldrup, Francisco J. Carranza-Chávez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer
Md. Bayazid Hossen, Md. Ariful Islam, Md. Selim Reza, et al.
Computers in Biology and Medicine (2022) Vol. 152, pp. 106411-106411
Closed Access | Times Cited: 22
Md. Bayazid Hossen, Md. Ariful Islam, Md. Selim Reza, et al.
Computers in Biology and Medicine (2022) Vol. 152, pp. 106411-106411
Closed Access | Times Cited: 22
Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 48, pp. 6827-6845
Open Access | Times Cited: 20
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 48, pp. 6827-6845
Open Access | Times Cited: 20
Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2438-2438
Open Access | Times Cited: 4
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2438-2438
Open Access | Times Cited: 4
Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies
Dimitrios Stefanoudakis
SynBio (2025) Vol. 3, Iss. 1, pp. 1-1
Open Access
Dimitrios Stefanoudakis
SynBio (2025) Vol. 3, Iss. 1, pp. 1-1
Open Access
Revolutionizing pancreatic cancer treatment with CAR-T therapy
Kirti Baghel, Sanjana Mehrotra, Vijay Prajapati
Advances in protein chemistry and structural biology (2025), pp. 331-353
Closed Access
Kirti Baghel, Sanjana Mehrotra, Vijay Prajapati
Advances in protein chemistry and structural biology (2025), pp. 331-353
Closed Access
The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Yaohui Fang, Chunlu Tan, Zhenjiang Zheng, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116849-116849
Closed Access
Yaohui Fang, Chunlu Tan, Zhenjiang Zheng, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116849-116849
Closed Access
Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening and Angiogenic Evaluation
Ruben Verloy, Angela Privat‐Maldonado, Jonas R.M. Van Audenaerde, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 450-450
Open Access
Ruben Verloy, Angela Privat‐Maldonado, Jonas R.M. Van Audenaerde, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 450-450
Open Access
Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma
Kush Savsani, Sivanesan Dakshanamurthy
Diseases (2024) Vol. 12, Iss. 7, pp. 149-149
Open Access | Times Cited: 3
Kush Savsani, Sivanesan Dakshanamurthy
Diseases (2024) Vol. 12, Iss. 7, pp. 149-149
Open Access | Times Cited: 3
Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer
Xiya Yuan, Haifu Huang, Changhui Yu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6507-6521
Closed Access | Times Cited: 2
Xiya Yuan, Haifu Huang, Changhui Yu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6507-6521
Closed Access | Times Cited: 2
The immunomodulatory role of IDO1-Kynurenine-NAD+ pathway in switching cold tumor microenvironment in PDAC
Anu R I, Kai‐Keen Shiu, Khurum Khan
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Anu R I, Kai‐Keen Shiu, Khurum Khan
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Group A streptococcal collagen-like protein 1 restricts tumor growth in murine pancreatic adenocarcinoma and inhibits cancer-promoting neutrophil extracellular traps
Emily A. Henderson, Abby D. Ivey, Soo Jeon Choi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Emily A. Henderson, Abby D. Ivey, Soo Jeon Choi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Keratin 17 modulates the immune topography of pancreatic cancer
Lyanne A Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Lyanne A Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Function and Therapeutic Potential of Non-Coding RNA in Ameloblastoma
Xu‐Feng Huang, Feihan Gu, Mingyu Zhao, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 643-653
Open Access | Times Cited: 1
Xu‐Feng Huang, Feihan Gu, Mingyu Zhao, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 643-653
Open Access | Times Cited: 1
Cancer-associated fibroblast-related prognostic signature predicts prognosis and immunotherapy response in pancreatic adenocarcinoma based on single-cell and bulk RNA-sequencing
Yajun Chen, Qican Deng, Hui Chen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Yajun Chen, Qican Deng, Hui Chen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies
James A. McCubrey, Stephen L. Abrams, Matilde Y. Follo, et al.
Advances in Biological Regulation (2022) Vol. 87, pp. 100917-100917
Open Access | Times Cited: 5
James A. McCubrey, Stephen L. Abrams, Matilde Y. Follo, et al.
Advances in Biological Regulation (2022) Vol. 87, pp. 100917-100917
Open Access | Times Cited: 5
Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
Yunjie Duan, Yongxing Du, Yongrun Mu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 4
Yunjie Duan, Yongxing Du, Yongrun Mu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 4
Keratin 17 modulates the immune topography of pancreatic cancer
Lyanne A Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Research Square (Research Square) (2024)
Open Access
Lyanne A Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Research Square (Research Square) (2024)
Open Access
Bulk anda single-cell transcriptome profiling reveals the molecular characteristics of T cell-mediated tumor killing in pancreatic cancer
Yinwei Dai, Ya-ting Pan, Danfeng Lin, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27216-e27216
Open Access
Yinwei Dai, Ya-ting Pan, Danfeng Lin, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27216-e27216
Open Access
Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma.
Kush Savsani, Sivanesan Dakshanamurthy
(2024)
Open Access
Kush Savsani, Sivanesan Dakshanamurthy
(2024)
Open Access
Enigmatic role of T cells in pancreatic ductal adenocarcinoma: An introspective study
Swetha Chintapanti, M. Hemalatha, Kotlapati Divya Teja, et al.
Elsevier eBooks (2024), pp. 159-171
Closed Access
Swetha Chintapanti, M. Hemalatha, Kotlapati Divya Teja, et al.
Elsevier eBooks (2024), pp. 159-171
Closed Access
